(OXSQ) Oxford Square Capital - Overview

Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 119m USD | Total Return: -32.9% in 12m

Corporate Debt, Equity Securities, Syndicated Loans, Preferred Stock
Total Rating 5
Safety 19
Buy Signal -1.19
Asset Management
Industry Rotation: -2.1
Market Cap: 119M
Avg Turnover: 4.26M
Risk 3d forecast
Volatility118%
VaR 5th Pctl20.6%
VaR vs Median6.18%
Reward TTM
Sharpe Ratio-0.87
Rel. Str. IBD5.4
Rel. Str. Peer Group5.7
Character TTM
Beta0.376
Beta Downside0.528
Hurst Exponent0.629
Drawdowns 3y
Max DD43.85%
CAGR/Max DD-0.12
CAGR/Mean DD-0.45
EPS (Earnings per Share) EPS (Earnings per Share) of OXSQ over the last years for every Quarter: "2021-03": 0.1, "2021-06": 0.06, "2021-09": 0.08, "2021-12": 0.09, "2022-03": 0.09, "2022-06": 0.09, "2022-09": 0.1, "2022-12": 0.13, "2023-03": 0.13, "2023-06": 0.23, "2023-09": 0.12, "2023-12": -0.16, "2024-03": 0.11, "2024-06": 0.0867, "2024-09": -0.0135, "2024-12": 0.09, "2025-03": 0.09, "2025-06": 0.08, "2025-09": 0.07, "2025-12": -0.1499, "2026-03": 0.05,
EPS CAGR: -43.80%
EPS Trend: -53.2%
Last SUE: -0.23
Qual. Beats: 0
Revenue Revenue of OXSQ over the last years for every Quarter: 2021-03: 9.35969, 2021-06: 7.842006, 2021-09: 9.797631, 2021-12: 10.175686, 2022-03: 9.86587, 2022-06: 9.939551, 2022-09: -6.713359, 2022-12: 11.914559, 2023-03: 12.941798, 2023-06: 15.877591, 2023-09: 11.106022, 2023-12: -3.739908, 2024-03: 1.383662, 2024-06: 7.959203, 2024-09: 2.195877, 2024-12: 6.273248, 2025-03: -5.123126, 2025-06: 7.417442, 2025-09: 1.655801, 2025-12: 8.102485, 2026-03: -21.795787,
Rev. CAGR: -16.31%
Rev. Trend: -59.4%
Last SUE: -3.96
Qual. Beats: -3

Warnings

Share dilution 26.1% YoY

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: OXSQ Oxford Square Capital

Oxford Square Capital Corp. (OXSQ) is a closed-end business development company (BDC) specializing in debt and equity investments within the technology sector. The firm targets small to mid-sized enterprises with annual revenues under $200 million, providing capital through secured and unsecured debt, preferred stock, and syndicated bank loans. BDCs like OXSQ are required by law to distribute at least 90% of their taxable income to shareholders, often resulting in higher dividend yields compared to traditional corporations.

The company focuses on a broad range of sub-sectors including software, semiconductors, and medical device technology, typically committing between $5 million and $30 million per transaction. By investing in senior and subordinated debt, the firm positions itself across various levels of the capital structure to manage risk while seeking returns. Investors may find it useful to evaluate OXSQ’s historical performance and portfolio health on ValueRay.

Founded in 2003 and based in Greenwich, Connecticut, the firm operates as a non-diversified management investment company. Its investment strategy aims for capital exits within a seven-year timeframe, primarily serving the financing needs of private companies that may lack access to traditional public equity markets.

Headlines to Watch Out For
  • CLO equity investment yields drive net investment income and dividend coverage
  • Floating rate debt exposure links interest income to Fed rate cycles
  • Credit quality of small-cap technology borrowers impacts net asset value
  • High management fees and operating expenses constrain total shareholder returns
  • Concentration in syndicated bank loans increases sensitivity to corporate default rates
Piotroski VR-10 (Strict) 2.0
Net Income: -36.1m TTM > 0 and > 6% of Revenue
FCF/TA: -0.12 > 0.02 and ΔFCF/TA -19.84 > 1.0
NWC/Revenue: 162.6% < 20% (prev 270.2%; Δ -107.6% < -1%)
CFO/TA -0.12 > 3% & CFO -32.1m > Net Income -36.1m
Net Debt (110.9m) to EBITDA (24332b): 0.00 < 3
Current Ratio: 15.19 > 1.5 & < 3
Outstanding Shares: last quarter (88.3m) vs 12m ago 26.14% < -2%
Gross Margin: 71.60% > 18% (prev 0.31%; Δ 7.13k% > 0.5%)
Asset Turnover: 8.33% > 50% (prev 3.96%; Δ 4.37% > 0%)
Interest Coverage Ratio: -3.03 > 6 (EBITDA TTM 24332b / Interest Expense TTM 10.1m)
Altman Z'' -7.44
A: 0.14 (Total Current Assets 40.9m - Total Current Liabilities 2.69m) / Total Assets 278.9m
B: -1.48 (Retained Earnings -413.3m / Total Assets 278.9m)
C: -0.11 (EBIT TTM -30.5m / Avg Total Assets 282.2m)
D: -2.65 (Book Value of Equity -412.4m / Total Liabilities 155.6m)
Altman-Z'' = -7.44 = D
What is the price of OXSQ shares?

As of May 24, 2026, the stock is trading at USD 1.38 with a total of 3,849,510 shares traded.
Over the past week, the price has changed by -22.42%, over one month by -31.25%, over three months by -21.50% and over the past year by -32.88%.

Is OXSQ a buy, sell or hold?

Oxford Square Capital has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold OXSQ.

  • StrongBuy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the OXSQ price?
Analysts Target Price 1.8 26.8%
Oxford Square Capital (OXSQ) - Fundamental Data Overview as of 23 May 2026
P/E Forward = 5.6211
P/S = 3.0362
P/B = 0.9864
P/EG = 1.1244
Revenue TTM = 23.5m USD
EBIT TTM = -30.5m USD
EBITDA TTM = 24332b USD
 Long Term Debt = unknown (none)
 Short Term Debt = 5.94m USD (from shortTermDebt, last fiscal year)
Debt = 151.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 110.9m USD (calculated: Debt 151.9m - CCE 40.9m)
Enterprise Value = 229.7m USD (118.8m + Debt 151.9m - CCE 40.9m)
Interest Coverage Ratio = -3.03 (Ebit TTM -30.5m / Interest Expense TTM 10.1m)
EV/FCF = -7.16x (Enterprise Value 229.7m / FCF TTM -32.1m)
FCF Yield = -13.96% (FCF TTM -32.1m / Enterprise Value 229.7m)
 FCF Margin = -136.4% (FCF TTM -32.1m / Revenue TTM 23.5m)
 Net Margin = -153.7% (Net Income TTM -36.1m / Revenue TTM 23.5m)
Gross Margin = 71.60% ((Revenue TTM 23.5m - Cost of Revenue TTM 6.68m) / Revenue TTM)
Gross Margin QoQ = none% (prev 85.21%)
Tobins Q-Ratio = 0.82 (Enterprise Value 229.7m / Total Assets 278.9m)
Interest Expense / Debt = 6.63% (Interest Expense 10.1m / Debt 151.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -24.1m (EBIT -30.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 15.19 (Total Current Assets 40.9m / Total Current Liabilities 2.69m)
Debt / Equity = 1.23 (Debt 151.9m / totalStockholderEquity, last quarter 123.3m)
Debt / EBITDA = 0.00 (Net Debt 110.9m / EBITDA 24332b)
 Debt / FCF = -3.46 (negative FCF - burning cash) (Net Debt 110.9m / FCF TTM -32.1m)
 Total Stockholder Equity = 146.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -12.81% (Net Income -36.1m / Total Assets 278.9m)
RoE = -6.46% (Net Income TTM -36.1m / Total Stockholder Equity 559.6m)
RoCE = -11.06% (EBIT -30.5m / Capital Employed (Total Assets 278.9m - Current Liab 2.69m))
 RoIC = -10.01% (negative operating profit) (NOPAT -24.1m / Invested Capital 241.2m)
 WACC = 6.14% (E(118.8m)/V(270.6m) * Re(7.30%) + D(151.9m)/V(270.6m) * Rd(6.63%) * (1-Tc(0.21)))
Discount Rate = 7.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 19.34%
 [DCF] Fair Price = unknown (Cash Flow -32.1m)
 EPS Correlation: -53.18 | EPS CAGR: -43.80% | SUE: -0.23 | # QB: 0
Revenue Correlation: -59.36 | Revenue CAGR: -16.31% | SUE: -3.96 | # QB: -3
EPS current Quarter (2026-06-30): EPS=0.04 | Chg30d=-33.33% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.04 | Chg30d=-33.33% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=0.17 | Chg30d=-32.00% | Revisions=-20% | GrowthEPS=-43.3% | GrowthRev=-15.0%
EPS next Year (2027-12-31): EPS=0.22 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+29.4% | GrowthRev=+0.1%